Literature DB >> 11703824

Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin.

I Kötter1, I Günaydin, N Stübiger, H Yazici, I Fresko, C C Zouboulis, Y Adler, I Steiert, B Kurz, D Wernet, B Braun, C A Müller.   

Abstract

The distribution of the different HLA-B*51 suballeles among patients with Behçet's disease (BD) of German (n=33) and Turkish (n=92) origin in comparison to their presence in the respective ethnically matched healthy control groups (German: n=325, Turkish: n=93) was studied. HLA-B*51x was significantly increased in both patient groups in comparison to the controls (Germans: 58% vs. 12%, OR 9.76, P<0.001; Turkish: 75% vs. 25%, OR 9.13, P<0.001). Molecular subtyping of B*51x revealed HLA-B*51011 and B*5108 as the predominant suballeles in both patient groups and controls although with a slightly increased frequency of HLA-B*5108 in the diseased individuals. HLA-B*5105 was the only further HLA-B*51x subtype detected in one Turkish patient heterozygous also for HLA-B*5101. HLA-B*5107 although present in a Turkish as well as German control was absent in the patient groups. There was also a tendency towards a higher degree of homozygosity for HLA-B*51x in both patient groups versus the matched controls (Germans: 10% in patients vs. 2,5% in controls; Turkish: 27% in patients vs. 13% in controls). Our study further supports previous hypothesis of an association of BD with B51 suballeles which share amino-acid residues at positions 63 and 67 as well as at positions 77-83 for specific peptide binding and natural killer (NK)-cell interactions. This applies to HLA-B*5101 and B*5108, but not to HLA-B*5107 different at position 67, which could be negatively associated with BD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703824     DOI: 10.1034/j.1399-0039.2001.580304.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  10 in total

Review 1.  Pathogenesis of Adamantiades-Behçet's disease.

Authors:  Christos C Zouboulis; Tobias May
Journal:  Med Microbiol Immunol       Date:  2003-03-05       Impact factor: 3.402

2.  Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.

Authors:  H Nagafuchi; M Takeno; H Yoshikawa; M S Kurokawa; K Nara; E Takada; C Masuda; M Mizoguchi; N Suzuki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

3.  HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.

Authors:  Ayfer Atalay; Sanem Yildiz-Demirtepe; Sinan Tatlipinar; Berna Sanli-Erdoğan; Veli Cobankara; Cem Yildirim; Hüseyin Bağci; Erol Omer Atalay
Journal:  Mol Biol Rep       Date:  2007-06-27       Impact factor: 2.316

4.  The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.

Authors:  Pablo Guasp; Eilon Barnea; M Francisca González-Escribano; Anaïs Jiménez-Reinoso; José R Regueiro; Arie Admon; José A López de Castro
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

Review 5.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

6.  HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.

Authors:  E Ashouri; P J Norman; L A Guethlein; A S Han; N Nemat-Gorgani; S J Norberg; A Ghaderi; P Parham
Journal:  HLA       Date:  2016-08-24       Impact factor: 4.513

7.  Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.

Authors:  Delia Kurzwelly; Claudia A Müller; Agnieszka Korfel; Eckhard Thiel; Michael Linnebank; Michael Weller; Ulrich Herrlinger
Journal:  J Neurooncol       Date:  2008-06-28       Impact factor: 4.130

Review 8.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

Review 9.  The immunogenetics of Behçet's disease: A comprehensive review.

Authors:  Masaki Takeuchi; Daniel L Kastner; Elaine F Remmers
Journal:  J Autoimmun       Date:  2015-09-05       Impact factor: 7.094

10.  The clinical feature of Behçet's disease in Northeastern China.

Authors:  Yingbin Shang; Shixin Han; Jiuhong Li; Qiushi Ren; Fangji Song; Hongduo Chen
Journal:  Yonsei Med J       Date:  2009-10-20       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.